|
[1]
|
Sedyaningsih, E.R., Isfandari, S., Soendoro, S. and Supari, S.F. (2008) Towards mutual trust, transparency and equity in virus sharing mechanism: The avian influenza case of Indonesia. Annals Academy of Medicine Singapore, 37, 482-488.
|
|
[2]
|
http://www.who.int/csr/disease/avian_influenza/avianinfluenza_factsheetJan2006/en/index.html
|
|
[3]
|
Cheung, C.L., Rayner, J.M., Smith, G.J.D., Wang, P., Naipospos, T.S.P., Zhang, J., Yuen, K.Y., Webster, R.G., Peiris, J.S.M. and Chen, H. (2006) Distribution of amantadine-resistant H5N1 avian influenza variants in Asia. The Journal of Infectious Diseases, 193, 1626-1629.
doi:10.1086/504723
|
|
[4]
|
Tu, Q., Pinto, L.H., Luo, G., Shaughnessy, M.A., Mullaney, D., Kurtz, S., Krystal, M. and Lamb, R.A. (1996) Characterization of M2 ion channel activity by BL-1743, an inhibitor of influenza A virus. Journal of Virology, 70, 4246-4252.
|
|
[5]
|
Li, K.S., Guan, Y., Wang, J., Smith, G.J., Xu, K.M., Duan, L., et al. (2004) Genesis of a highly pathogenic and potentially pandemic H5N1 influenza virus in eastern Asia. Nature, 430, 209-213. doi:10.1038/nature02746
|
|
[6]
|
Puthavathana, P., Auewarakul, P., Charoenying, P.C., Sangsiriwut, K., Pooruk, P., Boonnak, K., et al. (2005) Molecular characterization of the complete genome of human influenza H5N1 virus isolates from Thailand. Journal of General Virology, 86, 423-433.
doi:10.1099/vir.0.80368-0
|
|
[7]
|
Hay, A.J., et al. (1993) Options for the control of influenza virus II. Excerpta Medica, Amsterdam, 281-288.
|
|
[8]
|
Hay, A.J., Wolstenholme, A.J., Skehel, J.J. and Smith, M.H. (1985) The molecular basis of the specific anti-influenza action of amantadine. The EMBO Journal, 4, 3021-3024.
|
|
[9]
|
Hayden, F.G., Sperber, S.J., Belshe, R.B., Clover, R.D., Hay, A.J. and Pyke, S. (1991) Recovery of drug resistant influenza A virus during therapeutic use of rimantadine. Antimicrob Agents Chemother, 35, 1741-1747.
|
|
[10]
|
Peiris, J.S., Yu, W.C., Leung, C.W., et al. (2004) Re-emergence of fatal human influenza A subtype H5N1 disease. Lancet, 363, 617-619.
doi:10.1016/S0140-6736(04)15595-5
|
|
[11]
|
Le, Q.M., Kiso, M., Someya, K., et al. (2005) Avian flu: Isolation of drug-resistant H5N1 virus. Nature, 437, 1108.
doi:10.1038/4371108a
|
|
[12]
|
Jefferson, T., Demicheli, V., Rivetti, D., Jones, M., Di Pietrantonj, C., Rivetti, A. (2006) Antivirals for influenza in healthy adults: Systematic review. Lancet, 367, 303- 313. doi:10.1016/S0140-6736(06)67970-1
|
|
[13]
|
Bright, R.A., Shay, D.K., Shu, B., et al. (2006) Adamantane resistance among influenza A viruses isolated early during the 2005-2006 influenza season in the United States. Journal of the American Medical Association (JAMA), 295, 891-894. doi:10.1001/jama.295.8.joc60020
|
|
[14]
|
Hayden, F.G., Belshe, R.B., Clover, R.D., Hay, A.J., Oakes, M.G. and Soo, W. (1989) Emergence and apparent transmission of rimantadine-resistant influenza A virus in families. New England Journal of Medicine, 321, 1696-1702. doi:10.1056/NEJM198912213212502
|
|
[15]
|
Hall, C.B., Dolin, R., Gala, C.L., et al. (1987) Children with influenza A infection: Treatment with rimantadine. Pediatrics, 80, 275-282.
|
|
[16]
|
Shiraishi, K., Mitamura, K., Sakai-Tagawa, Y., Goto, H., Sugaya, N. and Kawaoka, Y. (2003) High frequency of resistant viruses harboring different mutations in amantadine-treated children with influenza. Journal of Infectious Diseases, 188, 57-61. doi:10.1086/375799
|
|
[17]
|
Englund, J.A., Champlin, R.E., Wyde, P.R., et al. (1998) Common emergence of amantadine- and rimantadine-resistant influenza A viruses in symptomatic immunocompromised adults. Clinical Infectious Diseases, 26, 1418-1424. doi:10.1086/516358
|
|
[18]
|
Hayden, F.G. (2001) Perpectives on antiviral use during pandemic influenza. Philosophical Transactions of the Royal Society B: Biological Sciences, 356, 1877-1884.
|
|
[19]
|
Russell, R.J., Haire, L.F., Stevens, D.J., Collins, P.J., Lin, Y.P., Blackburn, G.M., Hay, A.J., Gamblin, S.J. and Skehel, J.J. (2006) The structure of H5N1 avian influenza neuraminidase suggests new opportunities for drug design. Nature London, United Kingdom, 443, 45-49.
doi:10.1038/nature05114
|
|
[20]
|
Chachra, R. and Rizzo, R.C. (2008) Origins of resistance conferred by the R292K neuraminidase mutation via molecular dynamics and free energy calculations. Journal of Chemical Theory and Computation, 4, 1526-1540.
doi:10.1021/ct800068v
|
|
[21]
|
McKimm-Breschkin, J.L., Sahasrabudhe, A., Blick, T.J., McDonald, M., Colman, P.M., Hart, G.J., Bethell, R.C. and Varghese, J.N. (1998) Mutations in a conserved residue in the influenza virus neuraminidase active site decreases sensitivity to Neu5Ac2en derivatives. Journal of Virology, 72, 2456-2462.
|
|
[22]
|
Mishin, V.P., Hayden, F.G. and Gubareva, L.V. (2005) Susceptibilities of antiviral-resistant influenza viruses to novel neuraminidase inhibitors. Antimicrobial Agents and Chemotherapy, 49, 4515-4520.
doi:10.1128/AAC.49.11.4515-4520.2005
|
|
[23]
|
Sheu, T.G., Deyde, V.M., Okomo-Adhiambo, M., Garten, R.J., Xu, X., Bright, R.A., Butler, E.N., Wallis, T.R., Klimov, A.I. and Gubareva, L.V. (2008) Surveillance for neuraminidase inhibitor resistance among human influenza A and B viruses circulating worldwide from 2004 to 2008. Antimicrobial Agents and Chemotherapy, 52, 3284-3292.
|
|
[24]
|
Wetherall, N.T., Trivedi, T., Zeller, J., Hodges-Savola, C., McKimm-Breschkin, J.L., Zambon, M. and Hayden, F.G. (2003) Evaluation of neuraminidase enzyme assays using different substrates to measure susceptibility of influenza clinical isolates to neuraminidase inhibitors: Report of the neuraminidase inhibitor susceptibility network. Journal of Clinical Microbiology, 41, 742-750.
doi:10.1128/JCM.41.2.742-750.2003
|
|
[25]
|
McKimm-Breschkin, J.L., Trivedi, T., Hampson, A., Hay, A., Klimov, A., Tashiro, M., Hayden, F.G. and Zambon, M. (2003) Neuraminidase sequence analysis and susceptibilities of influenza virus clinical isolates to zanamivir and oseltamivir. Antimicrobial Agents and Chemotherapy, 47, 2264-2272. doi:10.1128/AAC.47.7.2264-2272.2003
|
|
[26]
|
Yen, H., Ilyushina, N.A., Salomon, R., Hoffmann, E., Webster, R.G. and Govorkova, E.A. (2007) Neuraminidase inhibitor-resistant recombinant A/Vietnam/1203/04 (H5N1) influenza viruses retain their replication efficiency and pathogenicity in vitro and in vivo. Journal of Virology, 81, 12418-12426. doi:10.1128/JVI.01067-07
|
|
[27]
|
Meijer, A., Lackenby, A., Hungnes, O., Lina, B., van der Werf, S., Schweiger, B., Opp, M., Paget, J., van de Kassteele, J., Hay, J. and Zambon, M. (2009) Oseltamivir-resistant influenza virus A (H1N1), Europe, 2007-08 season. Emerging Infectious Diseases, 15, 552- 560. doi:10.3201/eid1504.081280
|
|
[28]
|
Monto, A.S., McKimm-Breschkin, J.L., Macken, C., Hampson, A.W., Hay, A., Klimov, A., Tashiro, M., Webster, R.G., Aymard, M., Hayden, F.G. and Zambon, M. (2006) Detection of influenza viruses resistant to neuraminidase inhibitors in global surveillance during the first 3 years of their use. Antimicrobial Agents and Chemotherapy, 50, 2395-2402. doi:10.1128/AAC.01339-05
|
|
[29]
|
Tamura, D., Mitamura, K., Yamazaki, M., Fujino, M., Nirasawa, M., Kimura, K., Kiso, M., Shimizu, H., Kawakami, C., Hiroi, S., Takahashi, S., Hata, M., Minagawa, H., Kimura, Y., Kaneda, S., Sugita, S., Horimoto, T., Sugaya, N. and Kawaoka, Y. (2009) Oseltamivir-resistant influenza A viruses circulating in Japan. Journal of Clinical Microbiology, 47, 1424-1427.
doi:10.1128/JCM.02396-08
|
|
[30]
|
McNicholl, I.R. and McNicholl, J.J. (2001) Neuraminidase inhibitors: Zanamivir and oseltamivir. Annals of Pharmacotherapy, 35, 57-70.
doi:10.1345/aph.10118
|
|
[31]
|
Russell, R.J., Haire, L.F., Stevens, D.J., Collins, P.J., Lin, Y.P., Blackburn, G.M., Hay, A.J., Gamblin, S.J. and Skehel, J.J. (2006) The structure of H5N1 avian influenza neuraminidase suggests new opportunities for drug design, Nature, 443, 45-49. doi:10.1038/nature05114
|
|
[32]
|
Collins, P.J., Haire, L.F., Lin, Y.P., Liu, J., Russell, R.J., Walker, P.A., Skehel, J.J., Martin, S.R., Hay, A.J. and Gamblin, S.J. (2008) Crystal structures of oseltamivir- resistant influenza virus neuraminidase mutants, Nature, 453, 1258-1261. doi:10.1038/nature06956
|
|
[33]
|
http://www.ncbi.nlm.nih.gov/genomes/FLU/Database/nph-select.cgi?go=database
|
|
[34]
|
Altschul, S.F., Madden, T.L., Schaffer, A.A., Zhang, J.H., Zhang, Z., Miller, W. and Lipman D.J. (1997). Gapped BLAST and PSI-BLAST: A new generation of protein database search programs. Nucleic Acids Research, 25, 3389-3402. doi:10.1093/nar/25.17.3389
|
|
[35]
|
Zdobnov, E.M. and Apweiler, R. (2001) InterProScan—An integration platform for the signature-recognition methods in InterPro. Bioinformatics, 17, 847-848.
|
|
[36]
|
Arnold, K., Bordoli, L., Kopp, J. and Schwede, T. (2006). The SWISS-MODEL workspace: A web-based environment for protein structure homology modelling. Bioinformatics, 22, 195-201.
doi:10.1093/bioinformatics/bti770
|
|
[37]
|
Kiefer, F., Arnold, K., Künzli, M., Bordoli, L. and Schwede, T. (2009). The SWISS-MODEL repository and associated resources. Nucleic Acids Research, 37, D387-D392. doi:10.1093/nar/gkn750
|
|
[38]
|
Schwede, T., Kopp, J., Guex, N. and Peitsch, M.C. (2003) SWISS-MODEL: An automated protein homology-mo- deling server. Nucleic Acids Research, 31, 3381-3385.
doi:10.1093/nar/gkg520
|
|
[39]
|
Guex, N. and Peitsch, M.C. (1997) SWISS-MODEL and the Swiss-PdbViewer: An environment for comparative protein modelling. Electrophoresis, 18, 2714-2723.
doi:10.1002/elps.1150181505
|
|
[40]
|
Peitsch, M.C. (1995) Protein modeling by E-mail. Bio/ Technology, 13, 658-660.
|
|
[41]
|
http://www.pdb.org/pdb/home/home.do
|
|
[42]
|
Sali, A., Pottertone, L., Yuan, F., van Vlijmen, H. and Karplus, M. (1995) Evaluation of comparative protein modeling by MODELLER. Proteins, 23, 318-326.
doi:10.1002/prot.340230306
|
|
[43]
|
Fiser, R.K. and Sali, A. (2000) Modeling of loops in protein structures. Protein Science, 9, 1753-1773.
doi:10.1110/ps.9.9.1753
|
|
[44]
|
Laskowski, R.A., MacArthur, M.W., Moss, D.S. and Thornton, J.M. (1993) PROCHECK—A program to check the stereochemical quality of protein structures. Journal of Applied Crystallography, 26, 283-291.
doi:10.1107/S0021889892009944
|
|
[45]
|
Morris, A.L., MacArthur, M.W., Hutchinson, E.G. and Thornton, J.M. (1992) Stereochemical quality of protein structure coordinates. Proteins: Structure, Function, and Bioinformatics, 12, 345-364.
doi:10.1002/prot.340120407
|
|
[46]
|
Shen, M.-Y. and Sali, A. (2006) Statistical potential for assessment and prediction of protein structures. Protein Science, 15, 2507-2524. doi:10.1110/ps.062416606
|
|
[47]
|
Lüthy, R., Bowie, J.U. and Eisenberg, D. (1992) Assessment of protein models with three-dimensional profiles. Nature, 356, 83-85. doi:10.1038/356083a0
|
|
[48]
|
Ramachandran, G.N., Ramakrishnan, C. and Sasisekharan, V. (1963) Stereochemistry of polypeptide chain configurations. Journal of Molecular Biology, 7, 95-99.
doi:10.1016/S0022-2836(63)80023-6
|
|
[49]
|
Kabsch, W. and Sander, C. (1983) Biopolymers dictionary of protein secondary structure: Pattern recognition of hydrogen-bonded and geometrical features. Biopolymers, 22, 2577-2637. doi:10.1002/bip.360221211
|
|
[50]
|
http://pubchem.ncbi.nlm.nih.gov/
|
|
[51]
|
Wu, G., Robertson, D.H., Brooks, C.L.III and Vieth, M. (2003) Detailed analysis of grid-based molecular docking: A case study of CDOCKER—A CHARMm-based MD docking algorithm. Journal of Computational Chemistry, 24, 1549. doi:10.1002/jcc.10306
|
|
[52]
|
Stoll, V., Stewart, K.D., Maring, C.J., Muchmore, S., Giranda, V., Gu, Y.Y., Wang, G., Chen, Y., Sun, M., Zhao, C., Kennedy, A.L., Madigan, D.L., Xu, Y., Saldivar, A., Kati, W., Laver, G., Sowin, T., Sham, H.L., Greer, J. and Kempf, D. (2003) Influenza neuraminidase inhibitors: Structure-based design of a novel inhibitor series. Biochemistry, 42, 718-727. doi:10.1021/bi0205449
|
|
[53]
|
Lipinski, C.A., Lombardo, F., Dominy, B.W. and Feeney, P.J. (1997) Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Advanced Drug Delivery Reviews, 23, 3-25. doi:10.1016/S0169-409X(96)00423-1
|
|
[54]
|
Hatakeyama, S., Sugaya, N., Ito, M., Yamazaki, M., Ichikawa, M., Kimura, K., Kiso, M., Shimizu, H., Kawakami, C., Koike, K., Mitamura, K. and Kawaoka, Y. (2007) Emergence of influenza B viruses with reduced sensitivity to neuraminidase inhibitors. Journal of the American Medical Association (JAMA), 297, 1435-1442.
doi:10.1001/jama.297.13.1435
|
|
[55]
|
Hayden, F.G. (2006) Antiviral resistance in influenza viruses—Implications for management and pandemic response. New England Journal of Medicine, 354, 785-788.
doi:10.1056/NEJMp068030
|
|
[56]
|
Kiso, M., Mitamura, K., Sakai-Tagawa, Y., Shiraishi, K., Kawakami, C., Kimura, K., Hayden, F. G., Sugaya, N. and Kawaoka, Y. (2004) Resistant influenza A viruses in children treated with oseltamivir: Descriptive study. Lancet, 364, 759-765. doi:10.1016/S0140-6736(04)16934-1
|
|
[57]
|
Lackenby, A., Hungnes, O., Dudman, S.G., Meijer, A., Paget, W.J., Hay, A.J. and Zambon, M.C. (2008) Emergence of resistance to oseltamivir among influenza A (H1N1) viruses in Europe. Eurosurveillance, 13, 1-2.
|
|
[58]
|
Le, Q.M., Kiso, M., Someya, K., Sakai, Y.T., Nguyen, T.H., Nguyen, K.H.L., Pham, N.D., Ngyen, H.H., Yamada, S., Muramoto, Y., Horimoto, T., Takada, A., Goto, H., Suzuki, T., Suzuki, Y. and Kawaoka, Y. (2005) Avian flu: Isolation of drug-resistant H5N1 virus. Nature (London), 437, 1108. doi:10.1038/4371108a
|
|
[59]
|
Yamashita, M., Tomozawa, T., Kakuta, M., Tokumitsu, A., Nasu, H. and Kubo, S. (2009) CS-8958, a Prodrug of the new neuraminidase inhibitor R-125489, shows long-acting anti-influenza virus activity. Antimicrobial Agents and Chemotherapy, 53, 186-192. doi:10.1128/AAC.00333-08
|
|
[60]
|
Kiso, M., Kubo, S., Ozawa, M., Le, Q.M., Nidom, C.A., et al. (2001) Efficacy of the new neuraminidase inhibitor CS-8958 against H5N1 influenza viruses. PLoS Pathogens, 6, 1-10.
|